Leerink Partnrs Analysts Cut Earnings Estimates for MannKind
MannKind Corporation (NASDAQ:MNKD – Free Report) – Leerink Partnrs decreased their FY2026 earnings per share (EPS) estimates for shares of MannKind in a research note issued to investors on Wednesday, June 18th. Leerink Partnrs analyst F. Khurshid now forecasts that the biopharmaceutical company will post earnings per share of $0.14 for the year, down from […]
MannKind Corporation (NASDAQ:MNKD – Free Report) – Leerink Partnrs decreased their FY2026 earnings per share (EPS) estimates for shares of MannKind in a research note issued to investors on Wednesday, June 18th. Leerink Partnrs analyst F. Khurshid now forecasts that the biopharmaceutical company will post earnings per share of $0.14 for the year, down from […]
